888-899-6266        info@BioCoreUSA.com   
0 item(s) $0.00 
 
TISSUE ARRAYS
 
B-801OvaDifferent stage of ovary cancer tissue array (1999 WHO classification) with metastasis carcinoma, including pathology diagnosis, TNM and clinical stage, 80 cases/80 cores
Cores80Cases80
Row number8Column number10
Core Diameter(mm)1.5Thickness(µm)5.0
Tissue Array TypeFFPESpeciesHuman
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 60 minutes at 65℃ before the experiment.

3.Please choose a gentle repair method to avoid tissue detachment.

Product name:B-801Ova
 
Different stage of ovary cancer tissue array (1999 WHO classification) with metastasis carcinoma, including pathology diagnosis, TNM and clinical stage, 80 cases/80 cores
 
Price: $255.00
 
PLEASE SELECT TYPE
 
Qty:
 
To Check Overlapping Cases
 
 
Legend:
Lym
-Lymph node
Ova
-Ovary
 
Malignant (I)
 
Malignant (II)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIC)
 
Malignant (III)
 
Malignant (IIIC)
 
Malignant (IV)
 
Metastasis (*)
TISSUE  ARRAYS B-801Ova
1
2
3
4
5
6
7
8
9
10
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
LYM
LYM
LYM
LYM
LYM
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageType
A1169FOvarySerous papillary adenocarcinoma1T2bN0M0IIBMalignant
A2273FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignant
A3360FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignant
A4456FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
A5535FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
A6649FOvarySerous papillary adenocarcinoma2T2cN0M0IICMalignant
A7763FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignant
A8849FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
A9960FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignant
A101045FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
B11151FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignant
B21265FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
B31356FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
B41441FOvarySerous adenocarcinoma3T2cN0M0IICMalignant
B51556FOvarySerous adenocarcinoma3T2N0M0IIMalignant
B61639FOvarySerous adenocarcinoma with necrosis3T2N0M0IIMalignant
B71748FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
B81875FOvarySerous adenocarcinoma3T2N0M0IIMalignant
B91943FOvarySerous adenocarcinoma3T2N0M0IIMalignant
B102051FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
C12145FOvarySerous adenocarcinoma3T2bN0M0IIBMalignant
C22259FOvarySerous adenocarcinoma3T2N0M0IIMalignant
C32348FOvarySerous adenocarcinoma3T2bN0M0IIBMalignant
C42441FOvaryMucinous adenocarcinoma2T2aN0MOIIAMalignant
C52540FOvaryMucinous papillary adenocarcinoma2T2N0M0IIMalignant
C62662FOvarySerous adenocarcinoma2T2aN0M0IIAMalignant
C72750FOvaryMucinous adenocarcinoma3T2N0M0IIMalignant
C82841FOvaryMucinous adenocarcinoma3T2aN0M0IIAMalignant
C92960FOvaryEndometrioid adenocarcinoma with necrosis (sparse)*T2N0M0IIMalignant
C103050FOvaryEndometrioid adenocarcinoma2T2aN0M0IIAMalignant
D13168FOvaryEndometrioid adenocarcinoma3T2cN0M0IICMalignant
D23229FOvaryAdenocarcinoma3T2aN0M0IIAMalignant
D33347FOvaryMucinous adenocarcinoma3T2aN0M0IIAMalignant
D43447FOvaryClear cell carcinoma*T2aN0M0IIAMalignant
D53566FOvarySerous adenocarcinoma3T3N1M0IIICMalignant
D63652FOvarySerous papillary adenocarcinoma2T3cN1M0IIICMalignant
D73750FOvarySerous papillary adenocarcinoma2T3N1M0IIICMalignant
D83854FOvarySerous papillary adenocarcinoma2T3cN1M0IIICMalignant
D93951FOvarySerous papillary adenocarcinoma2T3N1M0IIICMalignant
D104058FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignant
E14148FOvarySerous adenocarcinoma3T3cN0M0IIICMalignant
E24238FOvarySerous adenocarcinoma3T1bN1M0IIICMalignant
E34357FOvarySerous adenocarcinoma3T3cN1M0IIICMalignant
E44453FOvarySerous adenocarcinoma3T3bN1M0IIICMalignant
E54562FOvarySerous adenocarcinoma3T3N0M0IIIMalignant
E64649FOvarySerous adenocarcinoma3T3N1M0IIICMalignant
E74765FOvarySerous adenocarcinoma3T3cN0M0IIICMalignant
E84847FOvarySerous adenocarcinoma3T3cN1M0IIICMalignant
E94942FOvarySerous adenocarcinoma3T3cN1M0IIICMalignant
E105046FOvarySerous adenocarcinoma3T2cN1M0IIICMalignant
F15156FOvarySerous adenocarcinoma3T3N1M0IIICMalignant
F25256FOvarySerous adenocarcinoma3T2N1M0IIICMalignant
F35342FOvarySerous adenocarcinoma3T1N1M0IIICMalignant
F45432FOvarySerous adenocarcinoma3T3cN0M0IIICMalignant
F55546FOvarySerous adenocarcinoma3T3aN1M0IIICMalignant
F65626FOvarySerous adenocarcinoma3T3CN1M0IIICMalignant
F75757FOvarySerous adenocarcinoma2T3cN1M0IIICMalignant
F85843FOvaryMucinous papillary adenocarcinoma1T3cN1M0IIICMalignant
F95948FOvaryMucinous adenocarcinoma3T3cN0M0IIICMalignant
F106052FOvaryTransitional cell carcinoma3T2N1M0IIICMalignant
G16155FOvaryTransitional cell carcinoma3T3cN0M0IIICMalignant
G26266FOvarySerous papillary adenocarcinoma2T3N0M1IVMalignant
G36369FOvarySerous papillary adenocarcinoma2T2N0M1IVMalignant
G46437FOvarySerous papillary adenocarcinoma2T3N1M1IVMalignant
G56565FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignant
G66654FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignant
G76755FOvarySerous papillary adenocarcinoma2T3cN1M0IIICMalignant
G86856FOvarySerous papillary adenocarcinoma2T3cN0M0IIICMalignant
G96956FOvarySerous papillary adenocarcinoma2T3cN1M1IVMalignant
G107048FOvarySerous adenocarcinoma2T3cN0M0IIICMalignant
H17143FOvarySerous adenocarcinoma3T2N0M1IVMalignant
H27265FOvarySerous adenocarcinoma3T2N0M1IVMalignant
H37341FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
H47451FOvarySerous adenocarcinoma3T1N0M0IMalignant
H57559FOvaryEndometrioid adenocarcinoma2--3T2N0M1IVMalignant
H67659FLymph nodeMetastatic serous adenocarcinoma3**Metastasis
H77753FLymph nodeMetastatic serous adenocarcinoma from omenta3**Metastasis
H87855FLymph nodeMetastatic serous adenocarcinoma from omenta2**Metastasis
H97947FLymph nodeMetastatic serous adenocarcinoma3**Metastasis
H108054FLymph nodeMetastatic serous adenocarcinoma3**Metastasis
I181
 
 
BioCoreUSA Corporation
6024 Ridge Ave, Suite 116-236
Philadelphia PA 19128
United States
 
CONTACT US
Email:
Customerservices@biocoreusa.com
Info@biocoreusa.com
TEL: 888-899 6266
SUPPORT
Delivery
Privacy Policy
Terms & Conditions
FAQs